Report Detail

Service & Software Global Drug Repurposing Serveice Market 2025 by Company, Regions, Type and Application, Forecast to 2031

  • RnM4655850
  • |
  • 05 December, 2025
  • |
  • Global
  • |
  • 100 Pages
  • |
  • GIR
  • |
  • Service & Software

According to our (Global Info Research) latest study, the global Drug Repurposing Serveice market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Drug Repurposing Serveice market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Drug Repurposing Serveice market size and forecasts, in consumption value ($ Million), 2020-2031
Global Drug Repurposing Serveice market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Drug Repurposing Serveice market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Drug Repurposing Serveice market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drug Repurposing Serveice
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drug Repurposing Serveice market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Anaxomics Biotech SL, Biovista, Chemotargets, IQVIA, Eurofins DiscoverX, NUVISAN, CD ComputaBio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Drug Repurposing Serveice market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Target-centric
Drug-centric
Disease-centric
Market segment by Application
Cardiovascular Disorders
Central Nervous Disorders
Oncology
Others
Market segment by players, this report covers
Anaxomics Biotech SL
Biovista
Chemotargets
IQVIA
Eurofins DiscoverX
NUVISAN
CD ComputaBio
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Drug Repurposing Serveice product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Drug Repurposing Serveice, with revenue, gross margin, and global market share of Drug Repurposing Serveice from 2020 to 2025.
Chapter 3, the Drug Repurposing Serveice competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Drug Repurposing Serveice market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug Repurposing Serveice.
Chapter 13, to describe Drug Repurposing Serveice research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Drug Repurposing Serveice by Type
    • 1.3.1 Overview: Global Drug Repurposing Serveice Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Drug Repurposing Serveice Consumption Value Market Share by Type in 2024
    • 1.3.3 Target-centric
    • 1.3.4 Drug-centric
    • 1.3.5 Disease-centric
  • 1.4 Global Drug Repurposing Serveice Market by Application
    • 1.4.1 Overview: Global Drug Repurposing Serveice Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Cardiovascular Disorders
    • 1.4.3 Central Nervous Disorders
    • 1.4.4 Oncology
    • 1.4.5 Others
  • 1.5 Global Drug Repurposing Serveice Market Size & Forecast
  • 1.6 Global Drug Repurposing Serveice Market Size and Forecast by Region
    • 1.6.1 Global Drug Repurposing Serveice Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Drug Repurposing Serveice Market Size by Region, (2020-2031)
    • 1.6.3 North America Drug Repurposing Serveice Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Drug Repurposing Serveice Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Drug Repurposing Serveice Market Size and Prospect (2020-2031)
    • 1.6.6 South America Drug Repurposing Serveice Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Drug Repurposing Serveice Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Anaxomics Biotech SL
    • 2.1.1 Anaxomics Biotech SL Details
    • 2.1.2 Anaxomics Biotech SL Major Business
    • 2.1.3 Anaxomics Biotech SL Drug Repurposing Serveice Product and Solutions
    • 2.1.4 Anaxomics Biotech SL Drug Repurposing Serveice Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Anaxomics Biotech SL Recent Developments and Future Plans
  • 2.2 Biovista
    • 2.2.1 Biovista Details
    • 2.2.2 Biovista Major Business
    • 2.2.3 Biovista Drug Repurposing Serveice Product and Solutions
    • 2.2.4 Biovista Drug Repurposing Serveice Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Biovista Recent Developments and Future Plans
  • 2.3 Chemotargets
    • 2.3.1 Chemotargets Details
    • 2.3.2 Chemotargets Major Business
    • 2.3.3 Chemotargets Drug Repurposing Serveice Product and Solutions
    • 2.3.4 Chemotargets Drug Repurposing Serveice Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Chemotargets Recent Developments and Future Plans
  • 2.4 IQVIA
    • 2.4.1 IQVIA Details
    • 2.4.2 IQVIA Major Business
    • 2.4.3 IQVIA Drug Repurposing Serveice Product and Solutions
    • 2.4.4 IQVIA Drug Repurposing Serveice Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 IQVIA Recent Developments and Future Plans
  • 2.5 Eurofins DiscoverX
    • 2.5.1 Eurofins DiscoverX Details
    • 2.5.2 Eurofins DiscoverX Major Business
    • 2.5.3 Eurofins DiscoverX Drug Repurposing Serveice Product and Solutions
    • 2.5.4 Eurofins DiscoverX Drug Repurposing Serveice Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Eurofins DiscoverX Recent Developments and Future Plans
  • 2.6 NUVISAN
    • 2.6.1 NUVISAN Details
    • 2.6.2 NUVISAN Major Business
    • 2.6.3 NUVISAN Drug Repurposing Serveice Product and Solutions
    • 2.6.4 NUVISAN Drug Repurposing Serveice Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 NUVISAN Recent Developments and Future Plans
  • 2.7 CD ComputaBio
    • 2.7.1 CD ComputaBio Details
    • 2.7.2 CD ComputaBio Major Business
    • 2.7.3 CD ComputaBio Drug Repurposing Serveice Product and Solutions
    • 2.7.4 CD ComputaBio Drug Repurposing Serveice Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 CD ComputaBio Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Drug Repurposing Serveice Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Drug Repurposing Serveice by Company Revenue
    • 3.2.2 Top 3 Drug Repurposing Serveice Players Market Share in 2024
    • 3.2.3 Top 6 Drug Repurposing Serveice Players Market Share in 2024
  • 3.3 Drug Repurposing Serveice Market: Overall Company Footprint Analysis
    • 3.3.1 Drug Repurposing Serveice Market: Region Footprint
    • 3.3.2 Drug Repurposing Serveice Market: Company Product Type Footprint
    • 3.3.3 Drug Repurposing Serveice Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Drug Repurposing Serveice Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Drug Repurposing Serveice Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Drug Repurposing Serveice Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Drug Repurposing Serveice Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Drug Repurposing Serveice Consumption Value by Type (2020-2031)
  • 6.2 North America Drug Repurposing Serveice Market Size by Application (2020-2031)
  • 6.3 North America Drug Repurposing Serveice Market Size by Country
    • 6.3.1 North America Drug Repurposing Serveice Consumption Value by Country (2020-2031)
    • 6.3.2 United States Drug Repurposing Serveice Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Drug Repurposing Serveice Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Drug Repurposing Serveice Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Drug Repurposing Serveice Consumption Value by Type (2020-2031)
  • 7.2 Europe Drug Repurposing Serveice Consumption Value by Application (2020-2031)
  • 7.3 Europe Drug Repurposing Serveice Market Size by Country
    • 7.3.1 Europe Drug Repurposing Serveice Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Drug Repurposing Serveice Market Size and Forecast (2020-2031)
    • 7.3.3 France Drug Repurposing Serveice Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Drug Repurposing Serveice Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Drug Repurposing Serveice Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Drug Repurposing Serveice Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Drug Repurposing Serveice Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Drug Repurposing Serveice Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Drug Repurposing Serveice Market Size by Region
    • 8.3.1 Asia-Pacific Drug Repurposing Serveice Consumption Value by Region (2020-2031)
    • 8.3.2 China Drug Repurposing Serveice Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Drug Repurposing Serveice Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Drug Repurposing Serveice Market Size and Forecast (2020-2031)
    • 8.3.5 India Drug Repurposing Serveice Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Drug Repurposing Serveice Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Drug Repurposing Serveice Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Drug Repurposing Serveice Consumption Value by Type (2020-2031)
  • 9.2 South America Drug Repurposing Serveice Consumption Value by Application (2020-2031)
  • 9.3 South America Drug Repurposing Serveice Market Size by Country
    • 9.3.1 South America Drug Repurposing Serveice Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Drug Repurposing Serveice Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Drug Repurposing Serveice Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Drug Repurposing Serveice Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Drug Repurposing Serveice Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Drug Repurposing Serveice Market Size by Country
    • 10.3.1 Middle East & Africa Drug Repurposing Serveice Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Drug Repurposing Serveice Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Drug Repurposing Serveice Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Drug Repurposing Serveice Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Drug Repurposing Serveice Market Drivers
  • 11.2 Drug Repurposing Serveice Market Restraints
  • 11.3 Drug Repurposing Serveice Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Drug Repurposing Serveice Industry Chain
  • 12.2 Drug Repurposing Serveice Upstream Analysis
  • 12.3 Drug Repurposing Serveice Midstream Analysis
  • 12.4 Drug Repurposing Serveice Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Drug Repurposing Serveice. Industry analysis & Market Report on Drug Repurposing Serveice is a syndicated market report, published as Global Drug Repurposing Serveice Market 2025 by Company, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Drug Repurposing Serveice market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report